ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 169 filers reported holding ALLAKOS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,973 | -46.7% | 12,323 | +2.4% | 0.00% | – |
| Q2 2023 | $52,464 | +6.1% | 12,033 | +8.3% | 0.00% | – |
| Q1 2023 | $49,440 | -67.3% | 11,110 | -38.0% | 0.00% | -100.0% |
| Q4 2022 | $150,971 | -83.7% | 17,930 | +104.8% | 0.00% | -87.5% |
| Q3 2021 | $927,000 | +26.8% | 8,755 | +2.2% | 0.01% | +33.3% |
| Q2 2021 | $731,000 | -16.6% | 8,563 | +12.1% | 0.01% | -25.0% |
| Q1 2021 | $877,000 | -11.7% | 7,642 | +7.8% | 0.01% | -11.1% |
| Q4 2020 | $993,000 | +65.8% | 7,092 | -3.6% | 0.01% | +50.0% |
| Q3 2020 | $599,000 | +51.6% | 7,357 | +33.8% | 0.01% | 0.0% |
| Q2 2020 | $395,000 | +55.5% | 5,497 | -3.8% | 0.01% | +50.0% |
| Q1 2020 | $254,000 | – | 5,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |